MagicMed’s mission is to unlock the full potential of psychedelic-derived medicines. The company is focused on the discovery and development of novel drug candidates, structurally related to classic psychedelics but with improved pharmaceutical characteristics.
Patented molecules can address multiple psychological indications
MagicMed has filed patents in psilocybin/N.N-dimethyltryptamine (DMT) derivatives and will expand to other psychedelics
Complementary Sector Market Share
Platform play for the industry that does not cannibalize on sector market share
De-risked Revenue Model with Blue Sky Potential
Revenue across the drug development stages with diversified upside potential
Licensing deals can be done with multiple partners
Conservative Capital Market Strategies
Designed to be quickly cash flow positive and to come to market for capital only upon accretive or transformative events
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.